Novo Nordisk threatens legal action over Hims Wegovy copy (updated) Kimberly Redmond 6, 2026// The basics: Novo Nordisk warns Hims & Hers over $49 compounded, copycat version of Wegovy Drugmaker says product infringes on its branded GLP-1 treatment Hims offering lower-cost compounded weight-loss alternatives amid soaring demand Dispute highlights growing tension between brand-name pharma, telehealth platforms Novo Nordisk vowed to take legal action against Hims & Hers after the telehealth platform launched a cheaper, copycat version of the pharmaceutical giants Wegovy GLP-1 weight loss pill
This GHRH-ghrelin synergy is well-documented in basic endocrine physiology
Bacteriostatic water is not designed to remove endotoxins, contaminants, or impurities from research compounds
Benefiber is a wheat dextrin fiber supplement
Its not necessary to avoid alcohol altogether, but being strategic helps minimise side effects
This comprehensive approach helps you stay on track and ensures that your medication remains a potent tool in your health transformation